Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study

PURPOSE: To evaluate the efficacy and safety of a single intravitreal dexamethasone implant (DXI) combined with intravitreal antivascular endothelial growth factor (anti-VEGF) therapy, in patients with neovascular age-related macular degeneration (wet-AMD) resistant to conventional treatment. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Giancipoli, Ermete, Pinna, Antonio, Boscia, Francesco, Zasa, Gianluigi, Sotgiu, Giovanni, Dore, Simone, D'Amico Ricci, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087571/
https://www.ncbi.nlm.nih.gov/pubmed/30151278
http://dx.doi.org/10.1155/2018/5612342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087571/
https://www.ncbi.nlm.nih.gov/pubmed/30151278
http://dx.doi.org/10.1155/2018/5612342

Ejemplares similares